| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 33.665 | 28.997 | 48.510 | 76.855 | 106.867 | 93.241 | 88.741 | 79.838 | 57.716 |
| Total Income - EUR | - | 33.667 | 33.381 | 51.738 | 84.085 | 106.926 | 93.549 | 88.751 | 79.847 | 57.716 |
| Total Expenses - EUR | - | 31.557 | 31.719 | 46.426 | 81.634 | 99.063 | 93.175 | 84.867 | 92.754 | 61.227 |
| Gross Profit/Loss - EUR | - | 2.110 | 1.663 | 5.313 | 2.451 | 7.862 | 374 | 3.884 | -12.908 | -3.510 |
| Net Profit/Loss - EUR | - | 1.698 | 1.322 | 4.774 | 1.616 | 6.976 | -446 | 2.996 | -13.716 | -4.088 |
| Employees | - | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 3 | 3 |
Check the financial reports for the company - Farmaben S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 13.499 | 12.291 | 26.984 | 32.797 | 57.664 | 49.693 | 26.423 | 13.786 | 8.185 |
| Inventories | - | 9.566 | 6.340 | 9.713 | 9.257 | 13.778 | 10.447 | 6.342 | 3.954 | 2.270 |
| Receivables | - | 1.346 | 5.181 | 16.666 | 14.657 | 26.772 | 20.173 | 16.079 | 789 | 4.600 |
| Cash | - | 2.587 | 771 | 605 | 8.883 | 17.114 | 19.073 | 4.001 | 9.042 | 1.316 |
| Shareholders Funds | - | 1.742 | 3.035 | 7.753 | 9.219 | 16.021 | 15.184 | 3.286 | -17.031 | -21.024 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 11.757 | 9.256 | 19.230 | 23.578 | 41.717 | 34.508 | 23.136 | 30.817 | 29.209 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmaben S.r.l.